EUVIMEDEUVIMED entdecken
Crossref

LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p/ARRDC3 signaling axis

Jinguang Luo iD, Huaixiang Tao, Long Chen, Hao Hu, Likai Mao, Han Guan

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgaf009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Jinguang Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Affiliated Hospital of Bengbu Medical University, No. 287 Changhuai Road, Zhihuai Street, Longzihu District, Bengbu 2330…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, MicroRNAs, Prostatic Neoplasms, Macrophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Key Project of Natural Science Research in Higher Education Institutions in Anhui Province, Open Project Fund of Anhui Provincial Key Laboratory of Immunology Fundamentals and Clinical Medicine for Chronic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-chain noncoding RNA (LncRNA) MEG3 significantly influences tumor microenvironment (TME) dynamics and macrophage polarization. However, its specific involvement in prostate cancer (PCa) progression remains unclear. MEG3 exhibited low expression in PCa, and immune infiltration analysis revealed a positive association with M1 macrophages infiltration and a negative association with M2 macrophages infiltration. Immunohistochemical analysis demonstrated increased MEG3 levels, corresponding with upregulated INOS (an M1 marker) and downregulated CD163 (an M2 marker). MEG3 expression was markedly elevated in LPS-induced M1 macrophages and notably reduced in IL-4-induced M2 macrophages. The overexpression of MEG3 significantly enhanced M1 macrophages polarization while suppressing M2 macrophages polarization. Using an online database and a dual luciferase reporter assay, miR-148a-3p was identified as a downstream target of MEG3. Reduced miR-148a-3p expression was observed in LPS-induced M1 macrophages, while an increase was noted in IL-4-induced M2 macrophages. Moreover, MEG3 overexpression’s impact on macrophage polarization was nullified following miR-148a-3p mimic transfection. ARRDC3 was validated as a downstream target of miR-148a-3p. The upregulation of ARRDC3 triggered by MEG3 overexpression was effectively suppressed by miR-148a-3p mimics. Additionally, Knockdown of ARRDC3 effectively counteracted the MEG3 overexpression-induced increase in M1 macrophages polarization while simultaneously mitigating the reduction in M2 macrophages polarization. Collectively, MEG3 exhibits reduced expression in PCa and correlates with macrophage infiltration and polarization. Specifically, it drives M1 macrophages polarization while suppressing M2 macrophages polarization via the miR-148a-3p/ARRDC3 axis, thereby impeding tumor immune evasion and restricting PCa progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingMicroRNAsProstatic NeoplasmsMacrophagesHumansMaleDisease ProgressionSignal TransductionGene Expression Regulation, NeoplasticTumor MicroenvironmentMacrophage ActivationCell Line, TumorCell ProliferationAnimals

Stichwörter der Autor:innen

LncRNA MEG3macrophagepolarizationprostate cancer

Substanzen

RNA, Long NoncodingMicroRNAsMIRN148 microRNA, humanMEG3 non-coding RNA, human

Autor:innen und Institutionen

  • Department of Urology, First Affiliated Hospital of Bengbu Medical University, No. 287 Changhuai Road, Zhihuai Street, Longzihu District, Bengbu 233099, China.
  • Anhui Provincial Key Laboratory of Immunology in Chronic Disease, Bengbu Medical University, No. 2600 Donghai Avenue, Longzi Lake District, Bengbu 233030, China.
  • Department of Urology, Affiliated Zhongda Hospital Affiliated to Southeast University, No. 87 Dingjiaqiao, Nanjing 210009, China.

ORCID-Profile: Jinguang Luo

Förderung

  • Key Project of Natural Science Research in Higher Education Institutions in Anhui Province
  • Open Project Fund of Anhui Provincial Key Laboratory of Immunology Fundamentals and Clinical Medicine for Chronic Diseases

Zitieren

APA

Luo, J., Tao, H., Chen, L., Hu, H., Mao, L., & Guan, H. (2025). LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p/ARRDC3 signaling axis. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf009

Vancouver

Luo J, Tao H, Chen L, Hu H, Mao L, Guan H. LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p/ARRDC3 signaling axis. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf009

BibTeX
@article{Luo2025,
  author = {Luo, Jinguang and Tao, Huaixiang and Chen, Long and Hu, Hao and Mao, Likai and Guan, Han},
  title = {LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p/ARRDC3 signaling axis},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgaf009}
}
Kostenlos starten →